BioLineRx rises 4%
BioLineRx shares increase as cancer trial begins, first patient dosed
BioLineRx shares increase as cancer trial begins, first patient dosed
BioLineRx shares increase as cancer trial begins, first patient dosed
BioLineRx shares increase as cancer trial begins, first patient dosed